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Introduction 
Contact Lens-Associated Papillary Conjunctivitis (CLAPC), formerly 
known as giant papillary conjunctivitis (GPC), has been defined as a 
papillary reaction of the tarsal conjunctiva of the upper eyelid due to 
contact lens (CL) wear, in which the papillae reach a diameter of 1.0mm 
or more, are elevated, and are associated with the discharge of mucus 
and/or the symptom of itching. Loss of CL wearing time and eventual CL 
intolerance often result from CLAPC. An understanding of GPe is given 
diagrammatically in Figure 1. GPC resembles vernal conjunctivitis, a 
condition of the eyelid long considered to be a hypersensitivity response. 
Methodology 
Survey 1: Two questionnaires were distributed, one in February 1991, the 
second in June 1991, on a total random sample of 172 CL wearers from all 
over Malta and Gozo, to investigate: 
the incidence of CLAPC in Malta as compared to abroad 
the influence of factors like geographic location, age, sex, a history 
of atopy and seasons on the condition 
the type of CLs and lens-cleaning solutions mostly irr.plicated in 
inducing/ aggravating the condition 
the therapy employed locally and how effective the patients found 
it 
Survey 2: An interview was carried out on a total of 212 non-CL wearers 
who visited Ophthalmic Out-patients clinics at Floriana, Mosta and 
Paola during Aug-Sept 1991 to investigate: 
the incidence of ocular allergies in this control group 
the influence of factors like geographic location, age, sex, a history 
of atopy and seasons 
the therapy employed locally and whether effective or not 
Results and Discussion 
52.9% (n=91) of CL wearers had suffered from CLAPC. On the other 
hand, only 18.9% (n=40) of non CL-wearers had suffered some form of 
ocular allergy such as allergic conjunctivitis, atopic keratoconjunctivitis, 
vernal conjunctivitis or hayfever conjunctivitis. The results seem to imply 
that CLs could be increasing the prevalence by a factor of three. Other 
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Figure 1. 
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FIGURE 1 - Suggested classification of giant papillary 
conjunctivitis syndromes. 
studies need to be carried out both locally and abroad to establish the 
exact role played by CLs in ocular allergies - whether they are an 
aggravating factor in patients with pre-existing ocular allergy for the 
development of CLAre. 
Whether a particular geographic location will eventually cause ocular 
allergy or not (CL-associated/not) is still unclear. A specific study has to 
be carried out on a very large population sample incorporating all the 
towns and villages where each person lives/works/spends his time, in 
order to get an unbiased idea of his/her exposure to antigens/pollutants 
and be able to correlate these with the development or progress of the 
condition. 
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The average age varied from 26 years in CL wearers to 46 years in non-
wearers. This is not so significant since it could have been the result of 
having more young individuals answering to the questionnaire which was 
sent by post and more elderly patients visiting Ophthalmic Clinics 
where the interview was carried out. In both study groups, ocular allergy 
was found to be more prevalent in females than in males. This however, 
was probably due to the fact that more females participated in the study 
than males. 
59.341 % (n=54) of CLAPC patients attended for regular eye checkups as 
compared to 20% (n=8) of non CL-wearing ocular allergy sufferers. 
Pharmacists, at this point, should emphasize patient compliance with 
regards to eye checkups to prevent later complications. 
54.946% (n=50) of CLAPC patients had a personal history of atopy as 
compared to 67.5% (n=27) of non CL-wearing ocular allergy sufferers. 
Moreover, more females than males were found to be atopic. These results 
seem to indicate that an atopic background could be a predisposing factor 
for this condition. It is still now known, however, whether atopic persons 
develop more CLAPC than non-atopic persons. Hence, the presence of 
atopy and particularly of ocular allergy is not an absolute 
contraindication for CL wear. 
Further studies on atopy in patients with CLAPC/vernal conjunctivitis 
and other ocular allergies could illustrate better the exact interaction per 
patient. 
The symptoms of eye irritation experienced by CL wearers and non-
wearers were basically the same. However, burning, redness, 
lacrimation, lid oedema, blurred vision and double vision were the 
predominating symptoms in CLAPC whereas itching, mucus, spasm and 
ENT problems such as catarrh and cough occurred more frequently in other 
ocular allergies, such as hay fever conjunctivitis or vernal catarrh. 
34.07% (n=31) of the CLAPC patients reported no seasonal correlation of 
their condition. 23.08% (n=9) on the other hand, implicated summer as 
the worst season for their symptoms. This correlated well with 45% of 
non CL-wearing ocular allergy sufferers. The Maltese summer climate 
could hence be an aggravating factor in ocular allergy. For this reason, 
further studies should be carried out to propose a form of prophylactic 
treatment which could be employed prior to the start of the implicated 
allergy season. 
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Table 1: Cumulative results of survey 1 & 2 
incidence 52.9% 18.9% 
(n=91) (n=40) 
CL Wearers Non CL 
Wearers 
average age 26 years 46 years 
Visits to 
Ophthalmic Clinic 
A history of atopy 
Symptoms of 
eye irritation 
ratio -3:1 
regular 
only when 
necessary 
personal 
both personal 
and family 
itching 
burning 
redness 
lacrimation 
puffed lids 
'mucus 
blurred vision 
double vision 
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-2:1 
59.341% 20% 
(n=54) (n=8) 
8.792% 17.5% 
(n=8) (n=7) 
54.9% 67.5% 
(n=50) (n=27) 
35.165% 32.5% 
(n=32) (n=13) 
80.2% 87.5% 
(n=73) (n=35) 
63.7% 42.5% 
(n=58) (n=17) 
68.1% 55% 
(n=62) (n=22) 
53.8% 50% 
(n=49) (n=20) 
26.4% 7.5% 
(n=24) (n=3) 
47.3% 52.5% 
(n=43) (n=21) 
20.9% 12/5% 
(n=19) (n=5) 
1.1% 0 
(n=l) (n=O) 
Table 1 cont. 
ENT problems 1.1% 2.5% 
(n=l) (n=1) 
spasm 0 2.5% 
.(n=O) (n=1) 
Seasonal particular season 57.15% 77.5% 
occurrence of implicated (n=52) (n=31) 
symptoms perennial 5.49% 15% 
sYmptoms (n=5) (n=6) 
association of 25.5% 45% 
symptoms with (n=23) (n=18) 
hayfever / sinusitis 
hypoallergenic 34.07% 7.5% 
cosmetics used (n=31) (n=3) 
medical treatment 65.9% 62.5% 
received (n=60) (n=25) 
The majority of patients reported no correlation of symptoms with 
hayfever / sinusitis. These contributed to 68.13% (n=62) of CL wearers as 
compared to 55% (n=22) of non-wearers. 17.58% (n=16) of CLAPC patients 
and 40% (n=16) of non CL wearers suffering from eye allergy however, 
associated their eye irritation symptoms with hayfever, and therefore 
could have been suffering from hayfever conjunctivitis. Future studies 
could further dev.elop this subject to establish exactly the antigens and 
anti genic responses involved. 
9nly 34.07% (n=31) of CL wearers and 7.5% (n=3) of non CL wearers, make 
use of hypoallergenic cosmetics. From the responses obtained, it can be 
deduced that there are still many individuals who are completely 
ignorant of the existence of hypoallergenic cosmetics. The pharmacist is 
in an excellent position to ensure the public is educated on this regard and 
to promote these products instead of the non-allergenic counterparts. 
Results obtained s):low that hydrophilic-CLAPC is ten times more 
common than hard CLAPe. This value agrees exactly with the ratio 
sl,ibmitted by Matthea R.Allansmith in the First Fisons International 
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Ophthalmology Workshop of the 5th March, 1987 on Diseases of the 
External Eye. 
The average time limit of wearing a CL is around two years for a 
hydrophilic lens and about 10 - 15 years for a hard (PMMA) lens. The 
'rejection' of the CL by the conjunctiva is an inflammatory process and, to 
a great extent, an immunologic one. There is a need to refine the plastic 
used for CLs by considering morc closely biosurface adhesion and the 
related inflammatory response to the nature of this biosurface. In this 
way, CLs could be worn for a longer period of time without the risk of 
developing conjunctival intolerance. 
48.2% (n=44) of the patients suffering from CLAPC reported that using an 
eye lubricant temporarily relieved their eye irritation such as itching 
and burning. This was probably due to the fact that frequent instillation 
of artificial tears flushes the ocular surface as well as the lens. 
47.25% of CLAPC patients changed solutions from preservative-
containing to preservative-free ones and 27.47% of them (n=.5) started 
using protein-removing effervescent tablets regularly, on their 
ophthalmologist's advice Pharmacists should advice on the importance 
of using preservative-free CL solutions and encourage all CL wearers to 
make use of these as well as the effervescent tablets. 
The responses received with regards to treatment employed clearly 
demonstrate that there is an absolute need for locally practising 
ophthalmologists to meet and reach a common protocol with regards to 
the management of CLAPe. 
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